Skip to main content

Table 1 MDM2 del1518 distribution and cancer risk (OR)

From: MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk

Cases/controls

Genotype del1518 n (%)

OR (95% CI) del1518

Fisher exact

OR (95% CI) del1518

Fisher exact

 

ins/ins

ins/del

del/del

Dominant modela

 

Recessive modelb

 

Healthy Controls

636 (34.0)

877 (46.9)

359 (19.2)

1.00

-

1.00

-

Ovarian cancer

484 (35.0)

655 (47.3)

246 (17.7)

0.96 (0.83–1.11)

0.576

0.91 (0.76–1.09)

0.316

Endometrial cancer

492 (35.0)

664 (47.3)

248 (17.7)

0.95 (0.83–1.10)

0.528

0.90 (0.76–1.08)

0.276

  1. adel/del + ins/del versus ins/ins
  2. bdel/del versus ins/del + ins/ins